ARTAN Bio Raises $200,000 in Decentralized Funding to Advance Longevity Science Through Mutation-Specific Codon Suppression

Summary

ARTAN Bio, a longevity biotechnology company based in St. Petersburg, Florida, completed a $200,000 seed raise to fund preclinical advancement of its proprietary engineered suppressor platform for mutation-specific codon suppression.